Skip to content

Refinement and Assessment of New Magnetic Resonance Imaging Technologies for Neurological Exams

Refinement and Assessment of New Magnetic Resonance Imaging (MRI) Technologies

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00739518
Enrollment
500
Registered
2008-08-21
Start date
2004-10-31
Completion date
2020-01-14
Last updated
2021-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nervous System Diseases

Keywords

Neurological, MRI

Brief summary

This study is being done to assess new Magnetic Resonance Imaging (MRI) technologies such as new hardware or software designed to improve MRI examinations of the brain, spine head and neck regions.

Detailed description

This study is being done to assess new Magnetic Resonance Imaging (MRI) technologies such as new hardware or software designed to improve MRI examinations of the brain, spine, and head & neck regions. Software and hardware are constantly being improved, new machines replace old machines, software is updated and improved as are the devices used to produce better MRI images.

Interventions

PROCEDUREMRI

Neurological MRI with new technology evaluation. The new technology may involve software or MRI scanning sequences. This is a long term research study that focuses on new technology that is constantly being created.

Sponsors

General Electric
CollaboratorINDUSTRY
Philips Medical Systems
CollaboratorINDUSTRY
University of Michigan
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* If you are a male or a non-pregnant female patient * Normal volunteer * presenting to MRI for a clinically-ordered neurological or head and neck MRI exam

Exclusion criteria

* Patients, who have electrically, magnetically or mechanically activated implants such as heart pacemaker, magnetic surgical clips, prostheses or implanted neurological stimulator. * Pregnant patients or patients who are lactating. * A patient who is claustrophobic

Design outcomes

Primary

MeasureTime frameDescription
Improvement in quality of MRI studies in Neuroradiology1 yearSpecific Measurement Are: 1. Scan speed - is the new method as fast or faster than regular method(s) 2. Signal to noise - Subjectively, or quantitatively do we get the same, better, or new contrast compared to the regular methods(s). 3. Image contrast - Subjectively, or quantitatively do we get the same or better resolution compared to the regular method(s). 4. Spatial resolution - Subjectively, or quantitatively do we get the same or better resolution compared to the regular method(s). 5. Artifact - Subjectively, or quantitatively do we get the better artifact reduction compared to the regular method(s). 6. Ergonomics - Is the new software easier to work or offer more information more cleanly than the regular software 7. Patient comfort - Subjectively, does the new software and/or hardware make the patient's MRI experience more comfortable.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026